University Of Nairobi
Clinical trials sponsored by University Of Nairobi, explained in plain language.
-
HIV drug resistance showdown: stay or switch?
Disease control Recruiting nowThis trial looks at what to do when the HIV virus becomes resistant to the drug dolutegravir. It compares staying on dolutegravir versus switching to another drug combination (darunavir/ritonavir) to see which better lowers the virus level. About 392 people with HIV and specific …
Phase: PHASE3 • Sponsor: University of Nairobi • Aim: Disease control
Last updated Jun 26, 2026 15:53 UTC
-
HIV resistance study seeks answers on dolutegravir failure
Knowledge-focused Recruiting nowThis study follows 6,600 people with HIV who have developed resistance to the drug dolutegravir. Researchers want to see if continuing the same medication with extra counseling can still suppress the virus. The goal is to learn more about how resistance develops and how to manage…
Sponsor: University of Nairobi • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:56 UTC